Ainnocence

Ainnocence

Biotechnology Research

Mountain View, California 720 followers

AI For Better Medicine

About us

Ainnocence is a next-generation biotech company with AI drug design platform. The company's third-generation AI system delivers lightning-fast virtual screening and multi-objective pharmacological profile optimization for small-molecule, antibody, Car-T and other complex therapeutic modalities. This platform provides a computational screening capacity of up to 10^10 protein sequences or chemical compounds within hours. The end results are a shortlist of candidates with a very high wet-lab hit rate, and a dramatically reduced discovery time and cost. To learn more, visit ainnocence.com.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Mountain View, California
Type
Privately Held
Founded
2021

Locations

Employees at Ainnocence

Updates

  • 🚀 Exciting advancements in the field of machine learning are continuously reshaping the way we solve complex problems. The recent article "Envisioning better benchmarks for machine learning PDE solvers" in Nature Machine Intelligence is a significant contribution to this evolving landscape. 🌐 Article link: https://lnkd.in/g-nXNH_N 📘 Driven by the pervasive application of machine learning in tackling partial differential equations

  • 🔬 Exciting Update in Neuroscience Research! 🔬 I am thrilled to share a pivotal development in our understanding of the brain's complex cellular architecture, as recently highlighted in the article "Author Correction: Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain" by Samuel E. Marsh. This significant study, published in Nature Neuroscience, leverages the advanced technique of single-cell sequencing to unravel the intricate web of glial signatures and eliminate potential artifacts and confounders in brain studies. 📊🔍 The analysis delves into both mouse and human brain tissues, providing a robust dataset that enhances our understanding of glial cell heterogeneity and its implications for neurological research. This achievement not only advances the field of neuroscience but also sets a new standard for precision in studying cellular interactions in the brain. 👉 Full Article: [Nature Neuroscience Article](https://lnkd.in/drCvEZCA) Published Date: 2024-12-13T00:00:00.000Z For researchers and practitioners in the field, this represents a quantifiable leap forward. By refining our understanding of glial cell signatures and distinguishing true biological signals from artifacts, we can more accurately interpret the complexities of neural environments. Join me in exploring this groundbreaking research that propels us closer to untangling the mysteries of the brain's cellular landscape! 🧠🔬 #Neuroscience #SingleCellSequencing #GlialSignatures #ResearchExcellence #NatureNeuroscience

  • 🔬 Exciting Advancements in Cancer Therapies 🌟 In the pursuit of novel cancer treatments, a foundational understanding of the mechanisms behind immune cell functionality within the tumour microenvironment has proven to be crucial. A recently published review in Nature Reviews Drug Discovery titled "Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer," by Sébastien Viel, delivers significant insights into this area. 📚 CD8 T cells and natural killer

  • 🚀 Exciting Scientific Breakthrough! 🚀 A newly published article in Nature Structural & Molecular Biology shines a light on the intricacies of human dicarboxylate transporter NaDC3. Utilizing advanced cryo-electron microscopy, the authors reveal detailed structures of the high-affinity sodium–dicarboxylate cotransporter in various complex states. This study unveils critical insights into substrate recognition, differentiation, and release mechanisms, along with vital regulatory details of transport domain movements. Understanding how NaDC3 facilitates dicarboxylate import into cells has significant implications for biochemical research and therapeutic development. These findings could pave the way for novel strategies to manipulate transporter functions and mitigate metabolic disorders. For more detailed insights, read the full study: https://lnkd.in/gRyTRZBa 🧬 #Biochemistry #StructuralBiology #ScientificDiscovery Published on 2024-12-02T00:00:00.000Z.

  • 🚀 Exciting advancements in clinical trials! Check out this article on Inventus Connect, "Inventus Connect: Revolutionizing Clinical Trials with Global eSIM Technology Delivering Better Patient Outcomes." 🌍 As published on December 6th, 2024, this piece on Fierce Biotech [Link: https://lnkd.in/edYTchNy] highlights a major achievement in using eSIM technology to enhance clinical trial efficiency and patient outcomes. 🔬 With a global eSIM solution, Inventus Connect is bridging geographical barriers and delivering seamless connectivity, ensuring better data collection and minimizing disruptions. This innovation significantly increases the accuracy of trial data while enhancing participation from diverse populations across the globe. The integration of eSIM technology is a game-changer, setting new standards in clinical trial operations. Dive into the article to understand its quantitative impact on patient outcomes! 📈#ClinicalTrials #Innovation #HealthcareTech

  • Exciting advancements in RNA biology with the publication of "An interpretable RNA foundation model for exploring functional RNA motifs in plants" in Nature Machine Intelligence. 🌿🧬 A groundbreaking interpretable RNA foundation model has been developed, achieving superior performance in plant RNA biology tasks. Trained on thousands of plant transcriptomes, this model is paving the way for new insights into regulatory RNA motifs. Major achievement: This model enables unprecedented exploration and discovery of functional RNA sequence and structure motifs across plant transcriptomes. Such innovations hold vast potential for enhancing our understanding of plant biology and may contribute significantly to advancements in agriculture, bioengineering, and conservation. As we venture into this new era of RNA research, the integration of machine learning with biology is proving crucial in uncovering the complex regulatory networks of life. This work stands as a testament to the power of interdisciplinary collaboration in solving intricate biological problems. Explore the full article here: [Nature Machine Intelligence Article](https://lnkd.in/gsGsP2xD) Publication Date: 2024-12-09T00:00:00.000Z #RNAResearch #PlantBiology #MachineLearning #ScientificInnovation #Biotechnology #Bioinformatics #NatureMachineIntelligence

  • 🔬 New insights have emerged from a groundbreaking study published in Nature Neuroscience: "Formation of long-term memory without short-term memory revealed by CaMKII inhibition" by Myung Eun Shin. 🧠 This research presents fascinating findings on the differentiation between short-term memory

  • 🚨 Exciting Developments in Pandemic Preparedness: Unveiling the Antiviral Target Compound Profile 🚨 The recent publication in Nature Reviews Drug Discovery, "Antiviral Target Compound Profile for Pandemic Preparedness," authored by James F. Demarest, presents groundbreaking advancements in our efforts to enhance global health security [https://lnkd.in/et92huZa]. In this comprehensive analysis, the article outlines a strategic framework for identifying and prioritizing antiviral targets that hold the potential to mitigate future pandemic threats. This work is crucial for streamlining the development of broad-spectrum antiviral therapies, which are indispensable in the fight against emergent viral pathogens. Key achievements highlighted in this publication include: 1. **Innovative Target Identification Methodology:** The research introduces a novel compound profiling strategy that is highly quantitative and integrated with cutting-edge bioinformatics tools. This methodology enables swift recognition of therapeutic targets that could lead to the inhibition of viral replication across diverse virus families. 2. **Comprehensive Data-Driven Approach:** Leveraging comprehensive datasets and high-throughput screening technologies, the study maps out viable antiviral targets. The inclusion of mechanistic insights and target accessibility data enhances our capacity to design more effective interventions. 3. **Enhanced Collaboration Networks:** The work underscores the importance of collaborative efforts between scientific communities and policymakers to accelerate the translation of research findings into actionable preparedness plans. As we stand on the cusp of a new era in pandemic preparedness, this pivotal work by Demarest et al. serves as a catalyst for innovation, urging the scientific community to focus on synergistic approaches that harness both classic virology and modern computational advances. Publication date: 2024-12-02 Read more: [https://lnkd.in/et92huZa] #PandemicPreparedness #AntiviralResearch #DrugDiscovery #GlobalHealth #InnovationInScience

  • Reflecting on a pivotal moment in scientific publishing, the release of "Looking back at the timely launch of Nature Structural Biology in 1994" offers profound insight into the evolutionary trajectory of structural biology. Published online on 28 November 2024, this article highlights the significant achievements that unfolded after the journal's inception, notably its role in advancing our understanding of molecular mechanisms at the atomic level. Nature Structural Biology, now Nature Structural & Molecular Biology, emerged during a time when the field was rapidly gaining momentum. This journal played a crucial role in providing a dedicated platform for pioneering research, facilitating global collaboration, and influencing a generation of scientific discovery. The retrospective also honors the contributions of influential figures like Christian Cambillau, whose work has significantly shaped the field. For more insights, read the full article here: https://lnkd.in/eXYCMgFZ

  • 🚀 Exciting developments in the biotech sector! Atlas Venture has announced the launch of a substantial $450M fund, just two years after its previous one. This strategic move underscores Atlas's commitment to supporting innovative biotech startups. 🔬 With a focus on transformative technologies and breakthrough therapies, this fund aims to fuel advancements in biotechnology that could reshape patient care and medical treatments. The substantial investment reflects a robust confidence in the sector’s ability to deliver cutting-edge solutions in healthcare. 📊 According to the article on Fierce Biotech, this fund is targeted at the next wave of pioneering biotechs, emphasizing the critical need for continuous funding and backing for early-stage life science innovations. Let's watch how this new funding initiative catalyzes progress in the biotech realm! For more insights, read the full article here: https://lnkd.in/eN2cyYEc #Biotech #Innovation #AtlasVenture #Investment #Healthcare

Similar pages

Funding

Ainnocence 2 total rounds

Last Round

Seed
See more info on crunchbase